The New Deal on State-based Medicines was announced to alleviate the problem of "expensive medical care"

On September 19, the General Office of the State Council issued the Opinions on Improving the National Basic Drug System. From the selection of basic drugs, production, circulation, use, payment, monitoring and other links to improve policies, comprehensively promote the construction of drug supply security system, focus on ensuring the safety and effective drug, reasonable prices, adequate supply, to alleviate the "expensive to see a doctor" problem.
the opinion, since the new round of medical reform, the establishment and implementation of the national basic drug system has played an important role in improving the drug supply guarantee system, safeguarding the basic drug use of the masses and reducing the burden of drug use on patients. At the same time, there are also problems such as incomplete adaptation to the needs of basic clinical drug use, lack of incentive mechanism for use, gap between the quality efficacy of imitation species and original research varieties, and inadequate supply guarantee mechanism.
the selection, production, circulation, use, payment, monitoring and other aspects of basic drugs, clear five aspects of policy measures.
is to dynamically adjust the optimization directory. The list of essential drugs is regularly evaluated and dynamically adjusted, with an adjustment period of not more than 3 years in principle. Highlight the clinical value of medicines, adhere to the between Chinese and Western medicine, to meet common diseases, chronic diseases, emergency rescue and other major clinical needs, taking into account children and other special groups and public health prevention and treatment of drug needs. Strengthen evidence-based decision-making, highlight the clinical value of drugs, standardize dosage form specifications, can oral non-injection, can muscle injection not infusion. We will support the development of Chinese medicine and encourage research and development and innovation in the pharmaceutical industry.
is to ensure the production and supply. Adhere to the direction of centralized procurement, the implementation of drug classification procurement. Do a good job in the upper and lower medical institutions drug convergence, promote the city (county) area of public medical institutions centralized procurement, promote drug prices. For essential drugs that are prone to shortage, the supply is guaranteed through market matchmaking measures such as determining reasonable purchase prices, fixed-point production, unified distribution or integration into reserves.
is fully equipped for priority use. Insist on the dominant position of essential drugs and clarify the proportion of basic drug use in public medical institutions. To carry out clinical use monitoring and carry out comprehensive clinical evaluation of drugs. We will deepen the reform of medical insurance payment methods, formulate standards for the payment of medical insurance for medicines, and guide rational diagnosis and treatment and rational drug use.
fourth is to reduce the burden of drug costs for the masses. In accordance with the procedures, priority should be given to the inclusion of essential drugs in the scope of the medical insurance catalogue, and the level of actual coverage should be gradually raised. Encourage local exploration of effective ways to reduce the burden on patients and minimize patient drug costs.
is to improve the level of quality and safety. We will carry out sampling of all-variety coverage of essential drugs, strengthen supervision and inspection of the production of essential drugs, and strengthen quality and safety supervision. For drug varieties evaluated by consistency, priority is given to the list of essential drugs in accordance with the procedure; (New Kangjie)